Analyze Diet

Developments in biological standardization.

Discontinued
Congress
Allergy and Immunology
Technology
Biological Products
Microbiology
Vaccines
Publisher:
Karger,. Basel : Karger
Frequency: Irregular
Country: Switzerland
Language: English
Author(s):
International Association of Biological Standardization., International Association for Biologicals.
Start Year:1974 - 1999
Identifiers
ISSN:0301-5149 (Print)
0301-5149 (Linking)
NLM ID:0427140
(DNLM):D08240000(s)
(OCoLC):00983297
Coden:DVBSA3
LCCN:93644425
Classification:W3 DE615E
Prevention of rotavirus diarrhoea in foals by parenteral vaccination of the mares: field trial.
Developments in biological standardization    May 15, 1998   Volume 92 253-257 
Barrandeguy M, Parreño V, Lagos Mármol M, Pont Lezica F, Rivas C, Valle C, Fernandez F.Many countries have reported rotavirus diarrhoea in foals. In Argentina it causes important economic losses to the horse industry. In this work we present the results obtained using an experimental vaccine in a farm with enzootic infection of rotavirus. A hundred mares were vaccinated 60 and 30 days before foaling with inactivated rotavirus SA11 (G3P2), H2 (G3P12), Lincoln (G6P1), with aluminum hydroxide as adjuvant; 65 mares were included in the unvaccinated, control group. To evaluate the vaccine, morbidity, duration of the diarrhoea and rotavirus shedding were recorded. Antibody levels were...
Use of ELISA to quantify the antitoxin content of commercial equine tetanus antitoxin.
Developments in biological standardization    January 1, 1996   Volume 86 336 
Kolbe DR.No abstract available
Establishing an acceptability threshold for equine influenza vaccines.
Developments in biological standardization    January 1, 1992   Volume 79 137-146 
Mumford JA, Wood J.Shortcomings in the original methods (based on haemagglutination of erythrocytes) used to measure potency of equine influenza vaccines and antibody responses stimulated by vaccines, coupled with the lack of a reliable challenge system in the target species, has hindered progress in identifying the antigenic content required to provide protection. Reliable methods are now available for measuring the haemagglutinin (HA) content of vaccines and the antibody responses they elicit. The development of challenge systems in the target species has allowed antibody levels consistent with protection to b...
Immunopathogenesis of equine infectious anemia lentivirus disease.
Developments in biological standardization    January 1, 1990   Volume 72 31-37 
McGuire TC, O'Rourke KI, Perryman LE.Virus replication and subsequent viremia are clearly correlated with clinical disease in EIAV infected horses. Termination of viremia is the result of specific immune responses. Recurrences of viremia are associated with antigenic variation of neutralization-sensitive epitopes. Immunosuppression experiments indicate that the eventual control of EIAV and development of carriers is mediated by the immune system. Even though the immune response to EIAV has a protective effect, immune responses also cause some of the lesions. At least one part of the anemia, erythrocyte destruction, is caused by t...
Equine infectious anemia: prospects for control.
Developments in biological standardization    January 1, 1990   Volume 72 49-57 
Issel CJ, McManus JM, Hagius SD, Foil LD, Adams WV, Montelaro RC.Equine infectious anemia has been managed in most countries by the imposition of testing and quarantine regulations. In the United States, about 700,000 of the more than 7,000,000 horses are tested annually. As long as the status of greater than 90% of the horse population remains unknown and horses are transported and congregate in a relatively unrestricted manner, EIA will continue to exact its toll. Therefore, it is incumbent on the scientific community to continue to develop and refine practical and sensitive diagnostic tests for EIA which will be used in an expanding market, to reduce the...
Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
Developments in biological standardization    January 1, 1990   Volume 72 39-48 
Derse D, Dorn P, DaSilva L, Martarano L.Equine infectious anemia virus (EIAV) encodes a tat gene which is closely related to the trans-activators encoded by the human and simian immunodeficiency viruses. Nucleotide sequence analysis of EIAV cDNA clones revealed that the tat message is composed of three exons; the first two encode tat and the third may encode rev.. Interestingly, EIAV tat translation is initiated at a non-AUG codon in the first exon of the message, perhaps allowing an additional level of gene regulation. The deduced amino acid sequence of EIAV tat, combined with functional analyses of tat cDNAs in transfected cells, ...
Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animals.
Developments in biological standardization    January 1, 1986   Volume 64 169-177 
Wood JM, Mumford J, Schild GC, Webster RG, Nicholson KG.Single-radial-immunodiffusion (SRD) provides a sensitive and reproducible in vitro assay for haemagglutinin (HA) concentration in inactivated influenza vaccines. The use of SRD for human influenza vaccine standardization and application for equine and avian influenza vaccines is discussed. In clinical trials, vaccine HA concentration measured by SRD has been shown to be directly related to antibody responses and to protection against challenge. The use of SRD may considerably reduce the usage of animals for potency testing of veterinary influenza vaccines.
[Monoclonal antibodies directed against equine blood group antigens].
Developments in biological standardization    January 1, 1984   Volume 57 77-83 
Metenier L, Grosclaude J, Meriaux JC.The chief application of blood typing in domestic animals is in the verification of parentage. However, the acquisition of good standardized reagents in sufficient quantity remains an obstacle for the development of this work. The production of monoclonal antibodies directed against blood group determinants offers an attractive means of improving both the quality and quantity of serological reagents, and could facilitate the definition of new specificities. Fusions between a mouse myeloma line and splenocytes from mice immunized with horse red cells have resulted in four hybridomas producing a...
Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
Developments in biological standardization    January 1, 1982   Volume 52 493-498 
Bryans JT, Allen GP.A chemically inactivated, adjuvanted vaccine prepared from a virulent strain of Equine herpesvirus I (EHV-I) was used to immunize pregnant Thoroughbred broodmares during a five-year field test designed to determine its safety and efficacy. Each mare in the vaccinated groups received 3 intramuscular injections of vaccine beginning immediately prior to and during the last half of pregnancy. Vaccine was injected at approximately 60-day intervals. The accumulated incidence of EHV-I abortions among vaccinated mares during the field trial period was 1.6/1000 as compared with an incidence of 6.8/1000...
Serum quality: an analysis of its components.
Developments in biological standardization    January 1, 1980   Volume 46 17-20 
Macleod AJ, Drummond O.Foetal and new born bovine sera, horse serum, human serum and human plasma, and protein solutions prepared from the by-products of human plasma fractionation have been analysed. Foetal bovine sera were found to have lower total protein (g/l) and % of gamma-globulin than the other sera studied while the potassium (mmol/1) was higher. Protease inhibitors could be detected in all specimens tested.
A three-year evaluation of four commercial equine influenza vaccines in ponies maintained in isolation.
Developments in biological standardization    June 1, 1977   Volume 39 341-346 
Burrows R, Spooner PR, Goodridge D.Ponies held in isolation for 40 months were vaccinated and revaccinated with four commercial equine influenza vaccines. Little or no HI antibody was detected after the first inoculation; second and subsequent annual revaccinations produced peak HI antibody titres between 7 and 14 days. Titres fell quickly between 14 and 28 days and less quickly thereafter. The decline of HI antibody appeared to be related more to the initial titre attained and to the period after vaccination than to the composition of the vaccine. The response to a first annual revaccination was superior to that produced by a ...
Field observations on influenza vaccination among horses in Britain, 1971-1976.
Developments in biological standardization    June 1, 1977   Volume 39 347-352 
Powell DG, Burrows R, Spooner P, Mumford J, Thomson G.The observations reported in this paper were obtained as part of a long term surveillance programme designed to monitor the efficacy of influenza vaccines and study the prevalence of influenza and other respiratory viruses among horses in Britain. Inactivated influenza vaccines were found to be effective in protecting horses from disease caused by influenza A/equine-1 but were less successful in protecting horses against influenza A/equine-2. The paper presents the clinical, epidemiological virological and serological findings obtained between 1971 and 1976.
Vaccination by the non-parenteral route of virus disease in the veterinary field.
Developments in biological standardization    January 1, 1976   Volume 33 33-40 
Menassé I.After a brief reference to the importance of the non-parenteral route of vaccination of domestic animals in general, the author deals, for each animal species separately, with the most important vaccines utilised by this method of administration. On the basis of bibliographical data, he describes the history of this use, discusses the results of the application in the field and draws the relative conclusions.
Immunization of man and animals against influenza by oral and intranasal routes.
Developments in biological standardization    January 1, 1976   Volume 33 171-177 
Boudreault A, Boulay G, Marois P, Pavilanis V.Live human and equine influenza virus strains modified by serial passage on allantois-on-shell system (AOS) in the presence of normal horse serum were administered orally or intranasally to volunteers or horses. Mostly mild clinical short-lasting reactions, replication in nasal mucosae, transmission to placebo recipients and significant local or circulating antibody rises were observed following administration to volunteers of strains modified by five or less serial passages on AOS in the presence of normal horse serum (NHS). Milder clinical reactions, no replication, no viral transmission and...